Mackenzie Financial Corp Vbi Vaccines Inc Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$0.73 - $23.4 $702 - $22,534	-963 Reduced 7.09%	12,610 $9,000
Q2 2022 Aug 10, 2022	BUY	$0.66 - $1.81 $2,333 - $6,400	3,536 Added 35.23%	13,573 $11,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $1,971 - $2,872	-892 Reduced 8.16%	10,037 $23,000
Q3 2021 Nov 08, 2021	BUY	$2.8 - $3.72 $30,601 - $40,655	10,929 New	10,929 $34,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.